lenalidomide - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
LENALIDE lenalidomide 5 mg capsules blister pack AUST R: 338518Active ingredients:
lenalidomide
Dosage form:
Capsule, hard
Sponsor:
Juno Pharmaceuticals Pty Ltd
Phone:
0388881288
|
From
30 Aug 2024
to
23 Sep 2024
|
Shortage status:
Current
Availability:
Limited Availability
Reason:
Unexpected increase in consumer demand
Management action:
Alternative generic products are available.
|
CIPLA LENALIDOMIDE lenalidomide 10 mg capsule blister pack AUST R: 307043Active ingredients:
lenalidomide
Dosage form:
Capsule
Sponsor:
Cipla Australia Pty Ltd
Phone:
0396964413
|
Deletion from market:
01 Dec 2024
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative generic products are available.
|
CIPLA LENALIDOMIDE lenalidomide 15 mg capsule blister pack AUST R: 307063Active ingredients:
lenalidomide
Dosage form:
Capsule
Sponsor:
Cipla Australia Pty Ltd
Phone:
0396964413
|
Deletion from market:
01 Dec 2024
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative generic products are available.
|
CIPLA LENALIDOMIDE lenalidomide 25 mg capsule blister pack AUST R: 307065Active ingredients:
lenalidomide
Dosage form:
Capsule
Sponsor:
Cipla Australia Pty Ltd
Phone:
0396964413
|
Deletion from market:
01 Dec 2024
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative generic products are available.
|
CIPLA LENALIDOMIDE lenalidomide 5 mg capsule blister pack AUST R: 307042Active ingredients:
lenalidomide
Dosage form:
Capsule
Sponsor:
Cipla Australia Pty Ltd
Phone:
0396964413
|
Deletion from market:
01 Dec 2024
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative generic products are available.
|